Since 2002, the American Foundation for the Blind
has been focusing on the interface design of diabetes-related self-management technology such as blood glucose meters, insulin pumps (IPs), blood pressure monitors, and insulin pens.1 The reason for this is that, of the 17.9 million people diagnosed with diabetes (another 5.7 million are believed to be undiagnosed2),
11% (2.6 million) are believed to have some level of visual impairment.3 It should be noted that visual problems
are more prevalent among type 2 diabetes patients who make up a smaller percentage of IP users.3